GSK-3 Inhibitors: Recent Developments and Therapeutic Potential

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|3|3|195-205

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.3, Iss.3, 2008-09, pp. : 195-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 1-19

Bentham Science Publishers

Access to resources Recommend Favorite

The Pathophysiological Roles of PI3Ks and Therapeutic Potential of Selective Inhibitors in Allergic Inflammation

By  

International Archives of Allergy and Immunology, Vol. 152, Iss. 1, 2010-06 ,pp. : 90-95

Karger

Access to resources Recommend Favorite

Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 70-80

Bentham Science Publishers

Access to resources Recommend Favorite

A comparative molecular dynamics simulation study to assess the exclusion ability of novel GSK3β inhibitors

By Hanumanthappa Pradeep   Krishnamurthy Rajanikant  

Medicinal Chemistry Research, Vol. 23, Iss. 6, 2014-06 ,pp. : 3092-3095

Springer Publishing Company

Access to resources Recommend Favorite

Elevation in 5‐FU‐induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 3, 2015-03 ,pp. : 201-207

John Wiley & Sons Inc

Access to resources Recommend Favorite